CN101730701B - 用于癌症治疗的水合的喜树碱酯晶体 - Google Patents
用于癌症治疗的水合的喜树碱酯晶体 Download PDFInfo
- Publication number
- CN101730701B CN101730701B CN200880013536XA CN200880013536A CN101730701B CN 101730701 B CN101730701 B CN 101730701B CN 200880013536X A CN200880013536X A CN 200880013536XA CN 200880013536 A CN200880013536 A CN 200880013536A CN 101730701 B CN101730701 B CN 101730701B
- Authority
- CN
- China
- Prior art keywords
- cancer
- camptothecine
- acid
- hydrate crystal
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CC[C@](*)(C(C=C(*C1)C(*2)C1=Cc1c2cccc1)=C(CO1)C=O)C1=O Chemical compound CC[C@](*)(C(C=C(*C1)C(*2)C1=Cc1c2cccc1)=C(CO1)C=O)C1=O 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
参数 | 水合的CZ48晶体 | CPT |
AUC0-8(ng·小时·ml-1)AUC0-24(ng·小时·ml-1)AUC0-∞(ng·小时·ml-1)Cmax(ng/mL)Tmax(小时)T1/2(小时)Ke(1/小时)MRT(小时) | ---1927.66±113.922233.44±396.05284.86±85.552.0±0.08.70±4.180.09±0.0311.62±4.34 | 136.43±26.94---146.70±34.7742.28±6.721.0±0.01.87±0.630.40±0.133.36±0.87 |
Claims (11)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/923,727 US7572803B2 (en) | 2007-10-25 | 2007-10-25 | Hydrated crystalline esters of camptothecin |
US11/923,727 | 2007-10-25 | ||
PCT/US2008/081047 WO2009055633A1 (en) | 2007-10-25 | 2008-10-24 | Hydrated crystalline esters of camptothecin for the treatment of cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101730701A CN101730701A (zh) | 2010-06-09 |
CN101730701B true CN101730701B (zh) | 2013-05-29 |
Family
ID=40229972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200880013536XA Active CN101730701B (zh) | 2007-10-25 | 2008-10-24 | 用于癌症治疗的水合的喜树碱酯晶体 |
Country Status (11)
Country | Link |
---|---|
US (1) | US7572803B2 (zh) |
EP (1) | EP2205605B1 (zh) |
JP (1) | JP5487111B2 (zh) |
KR (1) | KR20100082358A (zh) |
CN (1) | CN101730701B (zh) |
BR (1) | BRPI0816584A2 (zh) |
CA (1) | CA2703054C (zh) |
ES (1) | ES2396222T3 (zh) |
MX (1) | MX2010004332A (zh) |
RU (1) | RU2483071C2 (zh) |
WO (1) | WO2009055633A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013071053A1 (en) | 2011-11-11 | 2013-05-16 | The Christus Stehlin Foundation For Cancer Research | Rodent therapeutic model humanized for liver and bone marrow |
US9387257B2 (en) * | 2014-01-17 | 2016-07-12 | Academia Sinica | Lung cancer specific peptides for targeted drug delivery and molecular imaging |
US9675609B2 (en) | 2015-11-11 | 2017-06-13 | Cao Pharmaceuticals Inc. | Nano- and micro-sized particles of 20-camptothecin or derivative thereof and pharmaceutical compositions containing same, and treatment of cancers therewith |
TW202128189A (zh) * | 2019-11-20 | 2021-08-01 | 美商威瓦西塔腫瘤公司 | 使用喜樹鹼衍生物之癌症治療 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010031761A1 (en) * | 1996-01-30 | 2001-10-18 | Zhisong Cao | Derivatives of camptothecin and methods of treating cancer using these derivatives |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5552154A (en) | 1989-11-06 | 1996-09-03 | The Stehlin Foundation For Cancer Research | Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof |
US6080751A (en) | 1992-01-14 | 2000-06-27 | The Stehlin Foundation For Cancer Research | Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof |
US5527913A (en) | 1993-02-25 | 1996-06-18 | The Stehlin Foundation For Cancer Research | Methods for purifying camptothecin compounds |
US5352789A (en) | 1993-02-25 | 1994-10-04 | The Stehlin Foundation For Cancer Research | Methods for purifying camptothecin compounds |
US6096336A (en) | 1996-01-30 | 2000-08-01 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
US6407118B1 (en) | 1996-01-30 | 2002-06-18 | The Stehlin Foundation For Cancer Research | Derivatives of camptothecin and methods of treating cancer using these derivatives |
US5922877A (en) | 1997-08-05 | 1999-07-13 | The Stehlin Foundation For Cancer Research | Methods of preparing and purifying 9-nitro-20-camptothecin |
USRE38408E1 (en) | 1997-08-05 | 2004-01-27 | The Stehlin Foundation For Cancer Research | Methods of preparing and purifying 9-nitro-20-camptothecin |
US6228855B1 (en) | 1999-08-03 | 2001-05-08 | The Stehlin Foundation For Cancer Research | Aromatic esters of camptothecins and methods to treat cancers |
US6352996B1 (en) | 1999-08-03 | 2002-03-05 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
US6703399B2 (en) | 2002-05-06 | 2004-03-09 | The Stehlin Foundation For Cancer Research | Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds |
US6699875B2 (en) | 2002-05-06 | 2004-03-02 | The Stehlin Foundation For Cancer Research | Cascade esters of camptothecins and methods of treating cancer using these compounds |
JP4566128B2 (ja) * | 2003-02-25 | 2010-10-20 | 株式会社ヤクルト本社 | イリノテカン塩酸塩の結晶多形の製造方法 |
AR046579A1 (es) * | 2003-11-12 | 2005-12-14 | Smithkline Beecham Corp | Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica |
EP2082741A1 (en) * | 2005-09-20 | 2009-07-29 | Scinopharm Singapore Pte, Ltd. | Novel crystal form of irinotecan hydrochloride |
-
2007
- 2007-10-25 US US11/923,727 patent/US7572803B2/en active Active
-
2008
- 2008-10-24 CN CN200880013536XA patent/CN101730701B/zh active Active
- 2008-10-24 KR KR1020107011223A patent/KR20100082358A/ko not_active Application Discontinuation
- 2008-10-24 CA CA2703054A patent/CA2703054C/en active Active
- 2008-10-24 EP EP08841603A patent/EP2205605B1/en active Active
- 2008-10-24 ES ES08841603T patent/ES2396222T3/es active Active
- 2008-10-24 BR BRPI0816584-0A2A patent/BRPI0816584A2/pt not_active IP Right Cessation
- 2008-10-24 WO PCT/US2008/081047 patent/WO2009055633A1/en active Application Filing
- 2008-10-24 RU RU2010120810/04A patent/RU2483071C2/ru not_active IP Right Cessation
- 2008-10-24 JP JP2010531264A patent/JP5487111B2/ja not_active Expired - Fee Related
- 2008-10-24 MX MX2010004332A patent/MX2010004332A/es active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010031761A1 (en) * | 1996-01-30 | 2001-10-18 | Zhisong Cao | Derivatives of camptothecin and methods of treating cancer using these derivatives |
Non-Patent Citations (2)
Title |
---|
Zhisong Cao,et al..Alkyl Esters of Camptothecin and 9-Nitrocamptothecin: Synthesis, in Vitro Pharmacokinetics, Toxicity, and Antitumor Activity.《J. Med. Chem.》.1998,第41卷(第1期),31-37. * |
ZhisongCao et al..Alkyl Esters of Camptothecin and 9-Nitrocamptothecin: Synthesis |
Also Published As
Publication number | Publication date |
---|---|
RU2010120810A (ru) | 2011-11-27 |
KR20100082358A (ko) | 2010-07-16 |
JP2011500841A (ja) | 2011-01-06 |
EP2205605A1 (en) | 2010-07-14 |
EP2205605B1 (en) | 2012-11-21 |
RU2483071C2 (ru) | 2013-05-27 |
US7572803B2 (en) | 2009-08-11 |
JP5487111B2 (ja) | 2014-05-07 |
BRPI0816584A2 (pt) | 2015-03-03 |
CA2703054C (en) | 2017-08-22 |
CN101730701A (zh) | 2010-06-09 |
US20090111845A1 (en) | 2009-04-30 |
MX2010004332A (es) | 2010-05-20 |
ES2396222T3 (es) | 2013-02-20 |
CA2703054A1 (en) | 2009-04-30 |
WO2009055633A1 (en) | 2009-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2003528808A (ja) | カンプトセシン誘導体を含むリポソームプロドラッグおよびこれらのプロドラッグを使用する癌治療方法 | |
CN100406013C (zh) | 喜树碱衍生物 | |
CN105777770B (zh) | 一种饱和长链脂肪酸修饰的7-乙基-10-羟基喜树碱化合物及其长循环脂质体 | |
EP1186610B1 (en) | Dicarboxylato diammine platinum derivatives and compositions comprising them as anti-tumor agents | |
CN101730701B (zh) | 用于癌症治疗的水合的喜树碱酯晶体 | |
RU2393160C2 (ru) | Фармацевтическая композиция, содержащая эфир темозоломида | |
CN102731517A (zh) | 喜树碱衍生物、其制备方法及其在制备治疗肿瘤药物中的应用 | |
AU2002237884B2 (en) | Anticancer treatment using triptolide prodrugs | |
WO2020177748A1 (zh) | 季铵化修饰紫杉烷衍生物、其药物组合物和用途 | |
WO2015110040A1 (zh) | 苯丁酸氮芥衍生物、制备方法及应用 | |
US6703399B2 (en) | Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds | |
CN115403583B (zh) | 一种靶向降解fak蛋白的化合物及其用途 | |
CN101899051A (zh) | 1-氮杂呫吨酮-3-甲酰胺类化合物及制备方法和抗肿瘤用途 | |
WO2023091168A1 (en) | Formulated and/or co-formulated nanocarriers compositions containing immunogenic cell death (icd) inducing prodrugs useful in the treatment of cancer and methods thereof | |
CN100526324C (zh) | 制备反式-或顺式-二铵二氯二羟合铂(ⅳ)的方法及其用于制备药物有效物质的用途 | |
CN101328159A (zh) | 紫杉烷前体抗癌药及其药物组合物和用途 | |
CN100484940C (zh) | 一类水溶性喜树碱衍生物及其制备方法和应用 | |
CN115636863B (zh) | 含有马来酰亚胺片段的地塞米松衍生物及其制备方法 | |
Law et al. | Antitumor effect of mitoxantrone-containing liposomes | |
CN101541327A (zh) | 法呢基二苯并二氮杂酮的晶体形式 | |
CN104098594A (zh) | 生物素-鬼臼毒素酯化衍生物及其药物组合物和其制备方法与应用 | |
CA3194742A1 (en) | Formulated and/or co-formulated liposome compositions containing pd-1 antagonist prodrugs useful in the treatment of cancer and methods thereof | |
CN102649810A (zh) | 喜树碱衍生物、其制备方法和用途 | |
CN102086207A (zh) | 一类具有抗肿瘤活性的喜树碱衍生物 | |
JP2006193441A (ja) | 水溶性カンプトテシン製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: Texas, USA Patentee after: Stryn Research Foundation Address before: Texas, USA Patentee before: THE CHRISTUS STEHLIN FOUNDATION FOR CANCER RESEARCH |
|
TR01 | Transfer of patent right |
Effective date of registration: 20160129 Address after: Texas, USA Patentee after: CAO PHARMACEUTICALS Inc. Address before: Texas, USA Patentee before: Cao Zhisong Patentee before: B Giovanni pull Effective date of registration: 20160129 Address after: Texas, USA Patentee after: Cao Zhisong Patentee after: B Giovanni pull Address before: Texas, USA Patentee before: Stryn Research Foundation |